Under Armour, Inc. UA – On Thursday, we signaled interest in the UA Weekly $45-48 Calls and as you may recall, on that day we were provided the chance at gains spanning from 42-186% from contracts within the range. We mentioned the following morning that we expected to see further moves out of them. Our assumption proved accurate.
Multi-bag intraday gains were there for the taking, and the trading ranges in some cases exceeded any of the big gains we’d seen on Thursday by a wide margin:
$45 Calls – Trading Range: .87-2.05 – Max Gain: 136%
$45.50 Calls – Trading Range: .54-1.54 – Max Gain: 185%
$46 Calls– Trading Range: .20-1.10 – Max Gain: 450%
$46.50 Calls – Trading Range: .10-.57 – Max Gain: 470%
$47 Calls – Trading Range: .02-.20 – Max Gain: 900%
Bank of America Corp. BAC – We were also targeting BAC options last week, namely the BAC 07/15 $15 Calls which we signaled for observation on Wednesday morning. That day we witnessed a low of .51 in those calls, and the performance was quite respectable for the remainder of the week, culminating in a high of .85 on Friday.
We’re going to want to leave this play on our radar, with so much time remaining until their expiration, we may yet see further opportunities arise.
Lithium Corp. LTUM
We also want to make a quick mention of LTUM, which appeared on our watchlist on Friday, and subsequently made a notable move. The stock traded in a range from .10-.1349, for gains approaching 35%
Adding to the Radar
We took a look around this morning for a few new items of interest as we kick off another trading week, and came up with the following four stocks, three of which are in the biopharma sector. Half are catching our attention with fresh news out this morning, and the other half have attractive features on their charts.
EP Global Communications, Inc. EPGL
Protea Biosciences Group Inc. PRGB
Protea announces license agreement with Yale (Mon 8:00AM EDT)
TetraLogic Pharmaceuticals Corp. TLOG & StemCells Inc. STEM are also going on our watchlist after we’ve identified gaps on both charts in need of filling. We’re going to keep an eye on this pair over the next few sessions and see how it shakes out.
ADCF, ASUV, AVXL, HMPQ, ROSV, SFOR